State-of-the-Art Antigens
Most of Phadia’s antigens are produced in the baculovirus/insect cell system, which yields very pure antigens of high antigenicity to assure assays of excellent clinical sensitivity and specificity.
High purity and correct three-dimensional structure are the prerequisites for antigens used in reliable autoantibody assays.
The best but not the easiest way to meet these requirements is to use human recombinant antigens expressed in a eukaryotic system.
Using high volume fermentation of the cells and optimised scale-up methods in protein purification, we are able to produce huge amounts of antigen in one production batch and achieve a high lot-to-lot consistency in results.
Recombinant antigens
- In-house antigen production for highest quality and consistency
- Use of human recombinant antigens produced in the baculovirus/insect cell system
- Assays with excellent clinical sensitivity and exceptionally high clinical specificity
- Accurate, standardised and reproducible results
- Large antigen lots for consistency of results over time